Andrew Lawrence Taylor - 08 May 2024 Form 4 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)

Role: Chief Financial Officer
Signature: /s/ Matthew R. Schob, Attorney-in-Fact
Issuer symbol: OBIO
Transactions as of: 08 May 2024
Net transactions value: $0
Form type: 4
Filing time: 10 May 2024, 17:18:04 UTC
Previous filing: 24 Jul 2023
Next filing: 13 Dec 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OBIO	Common Stock, par value $0.0001 per share ("Common Stock")	Award	$0	+100,000	+36%	$0.000000	378,363	08 May 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest as follows: (i) 15,000 RSUs will vest on May 20, 2025, and (ii) the remaining 85,000 RSUs will vest in equal installments on August 20, 2025, November 20, 2025, December 20, 2025, May 20, 2026, August 20, 2026, November 20, 2026, March 25, 2027, May 20, 2027, August 20, 2027, November 20, 2027, March 25, 2028 and May 20, 2028, subject to the Reporting Person's continuous service through such dates.

Content

Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest as follows: (i) 15,000 RSUs will vest on May 20, 2025, and (ii) the remaining 85,000 RSUs will vest in equal installments on August 20, 2025, November 20, 2025, December 20, 2025, May 20, 2026, August 20, 2026, November 20, 2026, March 25, 2027, May 20, 2027, August 20, 2027, November 20, 2027, March 25, 2028 and May 20, 2028, subject to the Reporting Person's continuous service through such dates.